Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News OPKO Health Inc OPK

Healthcare Medical Care
OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company focuses on leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. Its segments include pharmaceutical and diagnostics. The pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain, Rayaldee product... see more

Recent & Breaking News (NDAQ:OPK)

OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire 13 days ago

OPKO Health's ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck

GlobeNewswire January 7, 2025

NextPlat Gains e-Commerce Access to Over 340 Million Consumers with Launch on JD.Com, China's Largest Online Retailer

PR Newswire December 10, 2024

OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference

GlobeNewswire November 20, 2024

NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo

PR Newswire November 18, 2024

NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 Results

PR Newswire November 14, 2024

Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates

GlobeNewswire November 8, 2024

OPKO Health Reports Third Quarter 2024 Business Highlights and Financial Results

GlobeNewswire November 7, 2024

Aspira Women's Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch®

GlobeNewswire November 7, 2024

OPKO Health to Report Third Quarter 2024 Financial Results on November 7, 2024

GlobeNewswire October 29, 2024

ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program

GlobeNewswire October 7, 2024

NextPlat Secures Four-Year Extension of OPKO Healthcare E-Commerce Program in China and Agrees to the Expansion of the Program into Japan

PR Newswire October 7, 2024

Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders

GlobeNewswire September 25, 2024

OPKO Health's ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development

GlobeNewswire September 23, 2024

Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health

PR Newswire September 16, 2024

Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates

GlobeNewswire August 9, 2024

OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results

GlobeNewswire August 7, 2024

OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024

GlobeNewswire August 1, 2024

OPKO Health Announces $100 Million Share Repurchase Program

GlobeNewswire July 18, 2024

OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA's Profit Share Payments

GlobeNewswire July 17, 2024